OptiNose Inc (OPTN)
1.01
+0.13
(+15.09%)
USD |
NASDAQ |
May 03, 16:00
1.003
-0.01
(-0.72%)
After-Hours: 20:00
OptiNose Total Assets (Quarterly): 107.73M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 107.73M |
September 30, 2023 | 101.41M |
June 30, 2023 | 106.07M |
March 31, 2023 | 114.92M |
December 31, 2022 | 144.22M |
September 30, 2022 | 105.27M |
June 30, 2022 | 122.83M |
March 31, 2022 | 133.82M |
December 31, 2021 | 166.07M |
September 30, 2021 | 131.92M |
June 30, 2021 | 139.52M |
March 31, 2021 | 157.95M |
December 31, 2020 | 188.81M |
September 30, 2020 | 181.02M |
Date | Value |
---|---|
June 30, 2020 | 153.05M |
March 31, 2020 | 174.17M |
December 31, 2019 | 172.65M |
September 30, 2019 | 149.38M |
June 30, 2019 | 166.57M |
March 31, 2019 | 192.99M |
December 31, 2018 | 216.99M |
September 30, 2018 | 237.62M |
June 30, 2018 | 259.95M |
March 31, 2018 | 220.56M |
December 31, 2017 | 241.14M |
September 30, 2017 | 55.14M |
June 30, 2017 | 63.96M |
December 31, 2016 | 41.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
101.41M
Minimum
Sep 2023
188.81M
Maximum
Dec 2020
143.02M
Average
144.22M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
Zevra Therapeutics Inc | 172.33M |
Madrigal Pharmaceuticals Inc | 640.55M |
Viking Therapeutics Inc | 967.52M |
Spero Therapeutics Inc | 182.39M |
Karuna Therapeutics Inc (DELISTED) | 1.336B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 194.34M |
Shareholders Equity (Quarterly) | -86.61M |
Debt to Equity Ratio | -1.504 |
Current Ratio | 0.5967 |
Net Debt Paydown Yield | -0.29% |